NCT04491266View on ClinicalTrials.gov

Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramide

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 9, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Safety Issues
Interventions
DIETARY_SUPPLEMENT

FBA

N-(1-carbamoyl-2-phenyl-ethyl) butyramide (FBA) has been developed.

DIETARY_SUPPLEMENT

placebo

maltodextrins

Trial Locations (1)

80131

University of Naples Federico II, Naples

All Listed Sponsors
lead

Federico II University

OTHER

NCT04491266 - Tolerability and Modulatory Action of the Butyrate Releaser N-(1-carbamoyl-2-phenyl-ethyl) Butyramide | Biotech Hunter | Biotech Hunter